Investor Presentaiton

What's Next for G7? ④ International Markets Extending launch to additional geographies: We are fully launched in 13 markets Expanding into additional regions in the coming months Dexcom 1. Dexcom, data on file, 2022 + Building Access Established reimbursement for G7 in US across our channels Commercial DME • Medicare Commercial pharmacy Quickly built broad reimbursement by mid- 2023 • Expanding Connected Solutions Leveraging world's most connected CGM ecosystem 1 to bring more choice to users Connected to several digital health apps at launch • Working with pump and pen partners to integrate G7 into insulin delivery systems 14

View entire presentation